Overall Status

Completed (63)

Unknown status (19)

Recruiting (16)

Not yet recruiting (10)

Active, not recruiting (6)

Terminated (6)

Withdrawn (4)

Enrolling by invitation (3)

Suspended (1)

Phase

n/a (30)

phase 4 (14)

phase 2 (11)

phase 3 (9)

phase 1 (8)

phase 2/phase 3 (5)

phase 1/phase 2 (3)

early phase 1 (1)

Study Documents

Intervention Type

drug (69)

other (22)

device (7)

diagnostic test (5)

procedure (4)

behavioral (3)

combination product (2)

biological (1)

dietary supplement (1)

Funder Type

Other (113)

Industry (11)

U.S. Fed (3)

NIH (1)

Study Type

Interventional (81)

Observational (44)

Observational [Patient Registry] (3)

Aminoglycosides

Showing 126 - 128 of 128

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Becker Muscular Dystrophy, Duchenne Muscular Dystrophy Trial run by the NINDS (Gentamicin)

Completed

Becker Muscular Dystrophy
Duchenne Muscular Dystrophy

Gentamicin

Bethesda, Maryland

National Institute of Neurological Disorders and Stroke (NINDS)

Mar 3, 2008

Infection Trial in Afula (ofloxacin, gentamicin)

Unknown status

Infection

Afula, Israel

Urology outpatient clinic, HaEmek MC

May 29, 2007

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

Unknown status

Enterobacteriaceae Infections
+4 more

Risk factors for infections due to ESBL+ Enterobacteriaceae
+2 more

Ancona, Italy
+5 more

Nov 28, 2006